510(k) K243406— cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test

Substantially Equivalent

Roche Molecular Systems, Inc.

Clearance details

Applicant: Roche Molecular Systems, Inc.
Product code: Code QOF
Advisory panel: Microbiology
Date received: 2024-11-01
Decision date: 2025-04-25
Decision: Substantially Equivalent
Clearance type: Dual Track
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.